To include your compound in the COVID-19 Resource Center, submit it here.

China makes headway on trade secret reform

As China readies to deliberate a draft of its first IP overhaul in over a decade, the government has recently passed two laws and one regulation that could help shield biopharma companies from IP loss.

Mark Cohen, head of the Asia IP project

Read the full 422 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE